行情

ICCC

ICCC

伊芙美尔医疗
NASDAQ

实时行情|Nasdaq Last Sale

5.52
-0.09
-1.55%
休市 16:00 08/07 EDT
开盘
5.69
昨收
5.61
最高
5.69
最低
5.37
成交量
1.12万
成交额
--
52周最高
8.13
52周最低
3.700
市值
3,983.70万
市盈率(TTM)
-25.4868
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ICCC价格均价为14.00,最高价位14.00,最低价为14.00。

EPS

ICCC 新闻

更多
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
GlobeNewswire · 1天前
ImmuCell sees Q2 product sales as high as $3M
Seeking Alpha - Article · 07/07 13:45
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
GlobeNewswire · 07/07 13:00
ImmuCell Sees Prelim. Q2 Total Product Sales $3M, Up 9% YoY
PORTLAND, Maine, July 07, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
Benzinga · 07/07 12:19
ImmuCell Receives $500,000 Loan from the Maine Technology
GlobeNewswire · 06/16 13:00
Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT
Q1 2020 ImmuCell Corp Earnings Call
Thomson Reuters StreetEvents · 05/18 15:48
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/14 19:14
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced it will participate in a
PR Newswire · 05/14 17:35

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

ICCC 简况

ImmuCell Corporation是一家动物保健公司。该公司主要在奶牛与牛肉行业从事提高奶牛健康与生产力的产品的开发、采购、制造和销售业务。该公司已开发能够为新生奶牛与肉牛提供即时免疫力的产品,并正在开发其现有的针对乳腺炎的产品扩展。该公司的先导产品First Defense利用其疫苗与乳蛋白纯化技术由母牛的初乳制成。该公司的擦拭乳制品湿巾由能够进行有效清洁的无纺布制成。该公司还开发用于集液罐及单独牛样品监测的加州乳腺炎检测(CMT),以确定乳腺炎检四格验盘中哪一个的牛奶所属乳房患有乳腺癌。该公司的产品开发计划是一种治疗哺乳期乳牛亚临床乳腺炎的基于乳酸链球菌素的乳房内治疗Mast Out。
展开

微牛提供ImmuCell Corporation(NASDAQ-ICCC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ICCC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ICCC股票基本功能。